What is a stock summary page? Click here for an overview.
Business Description
ClearPoint Neuro Inc
NAICS : 339112
SIC : 3841
ISIN : US55347P2092
Description
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.64 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 9.5 | |||||
| Beneish M-Score | -3.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.9 | |||||
| 3-Year EBITDA Growth Rate | -2.4 | |||||
| 3-Year EPS without NRI Growth Rate | -0.5 | |||||
| 3-Year FCF Growth Rate | 18.1 | |||||
| 3-Year Book Growth Rate | -23.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 2.39 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 36.52 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.7 | |||||
| 9-Day RSI | 49.28 | |||||
| 14-Day RSI | 45.51 | |||||
| 3-1 Month Momentum % | 4.3 | |||||
| 6-1 Month Momentum % | 43.68 | |||||
| 12-1 Month Momentum % | 149.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.22 | |||||
| Quick Ratio | 2.56 | |||||
| Cash Ratio | 1.94 | |||||
| Days Inventory | 225.07 | |||||
| Days Sales Outstanding | 41.36 | |||||
| Days Payable | 25.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.3 | |||||
| Shareholder Yield % | -3.01 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.92 | |||||
| Operating Margin % | -62.91 | |||||
| Net Margin % | -60.26 | |||||
| FCF Margin % | -28.51 | |||||
| ROE % | -66.47 | |||||
| ROA % | -41.43 | |||||
| ROIC % | -108.68 | |||||
| 3-Year ROIIC % | -110.11 | |||||
| ROC (Joel Greenblatt) % | -179.9 | |||||
| ROCE % | -57.71 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.02 | |||||
| PB Ratio | 14.98 | |||||
| Price-to-Tangible-Book | 15.31 | |||||
| EV-to-EBIT | -17.86 | |||||
| EV-to-EBITDA | -19.76 | |||||
| EV-to-Revenue | 11.23 | |||||
| EV-to-FCF | -40.36 | |||||
| Price-to-GF-Value | 1.11 | |||||
| Price-to-Median-PS-Value | 1.91 | |||||
| Price-to-Net-Current-Asset-Value | 19.41 | |||||
| Price-to-Net-Cash | 59.91 | |||||
| Earnings Yield (Greenblatt) % | -5.6 | |||||
| FCF Yield % | -2.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CLPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ClearPoint Neuro Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 31.39 | ||
| EPS (TTM) ($) | -0.7 | ||
| Beta | 0.95 | ||
| 3-Year Sharpe Ratio | 0.48 | ||
| 3-Year Sortino Ratio | 1 | ||
| Volatility % | 95.38 | ||
| 14-Day RSI | 45.51 | ||
| 14-Day ATR ($) | 0.920527 | ||
| 20-Day SMA ($) | 13.72875 | ||
| 12-1 Month Momentum % | 149.32 | ||
| 52-Week Range ($) | 5.105 - 19.22 | ||
| Shares Outstanding (Mil) | 27.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ClearPoint Neuro Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ClearPoint Neuro Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
ClearPoint Neuro Inc Frequently Asked Questions
What is ClearPoint Neuro Inc(CLPT)'s stock price today?
The current price of CLPT is $13.78. The 52 week high of CLPT is $19.22 and 52 week low is $5.11.
When is next earnings date of ClearPoint Neuro Inc(CLPT)?
The next earnings date of ClearPoint Neuro Inc(CLPT) is 2025-05-07 Est..
Does ClearPoint Neuro Inc(CLPT) pay dividends? If so, how much?
ClearPoint Neuro Inc(CLPT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers